SUMMARY | Position: LONG | Upside target: R27.00 | Reward / risk ratio: Recommended stop-loss: R18.00
RECOMMENDATION: BUY
Analysts:
Peet Serfontein, Jalpa Bhoolia
Life Healthcare (LHC) is an international healthcare provider. Its geographic footprint spans across southern Africa, the United Kingdom, and Europe. In southern Africa, the group operates a hospital division and a healthcare services division. The international segment includes Alliance Medical Group (AMG) and Life Molecular Imaging (LMI).
Fundamentally, we view Life Healthcare as a solid player within the healthcare space. We expect a post-Covid-19 pickup in elective surgeries to remain supportive of volumes and margins, which may translate into decent bottom-line growth over the medium term. The recent approval of Alzheimer drugs by the FDA in the US holds potential for its patented radioisotope tracer used in the diagnosis of the disease.
Technically, a price that appears to be in the upper range of a declining channel pattern makes the share…